Don't want ads? Subscribe or login now.

Accredo Pays $45M To Escape Novartis Exjade Kickback Suit

By Margaret Harding McGill · April 30, 2015, 4:21 PM EDT

Specialty pharmacy Accredo Health Group Inc. agreed to pay $45 million to settle allegations it participated in a patient referral kickback scheme with Novartis Pharmaceutical Corp. involving refill prescriptions of an...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Settlement

Case Information

Case Title

United States of America, ex rel, et al v. Novartis Pharmaceuticals Corporation

Case Number

1:11-cv-08196

Court

New York Southern

Nature of Suit

Other Statutes: False Claims Act

Date Filed

November 14, 2011

Recent Articles By Margaret

January 04, 2016
Justices Asked To Mull Preemption Of NC Workers' Comp Law
December 14, 2015
High Court's DirecTV Ruling Shows No Leeway On Arbitration
December 14, 2015
High Court Boosts Federal Arbitration Rule In DirecTV Case
October 06, 2015
High Court Seeks Its Proper Role In DirecTV Arbitration Row
September 01, 2015
Spokeo Will Impact Verizon ERISA Suit, 5th Circ. Told
August 19, 2015
Price Data Crucial In Retrans Deals, Cable Cos. Tell FCC
August 19, 2015
4th Circ. Upholds End Of IRS Agent's Transgender Bias Suit
July 10, 2015
Locking Up AT&T 'Prisoner' Shirts Just Makes Sense: DC Circ.
June 30, 2015
Tech Cos. Agree To Pay $75.5M To Settle FCA Claims
June 09, 2015
Bayer Must Face FCA Claims Over Off-Label Trasylol Marketing